Page 43 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Photo: ANDINA/Juan Carlos Guzmán Negrini 09:30 | Lima, Mar. 6. The Ministry of Health (Minsa) on Saturday affirmed that the Sinopharm COVID-19 vaccine reached an effectiveness of 79.34% in phase III of clinical trials in the United Arab Emirates (UAE), according to the Beijing Institute of Biological Products. Minsa made this clarification after Ernesto Bustamante said in a local TV program that Sinopharm vaccine s Wuhan strain had only 33% effectiveness, while the Beijing strain vaccine had 11.5%. In a statement, Minsa affirmed that in addition to the reports of those trials in the UAE the scientific journal The Lancet published results of phase I and II studies indicating the neutralizing capacity of the vaccine in different age groups.

Saudi arabiaMinistry of healthUnited arab emiratesErnesto bustamanteSalud minsaInstitute of biological productsMinistry of health minsa onBeijing instituteGeneral directoratePeruvian stateMinisterio de saludPeru sinopharm covid 19 vaccine 39s efficacy is 79 34சவுதி அரேபியாஅமைச்சகம் ஆஃப் ஆரோக்கியம்ஒன்றுபட்டது அரபு அமீரகங்கள்அர்நெஸ்டோ புஸ்டமண்டே